Feed TMDX
TM

TransMedics TMDX · NASDAQ

$70.78 -7.50% (-$5.74)

Market cap
$2.64B
Enterprise value
$3.04B
P/E
17.4x
Forward P/E
45.3x
PEG
0.0x
P/S
4.0x
P/FCF
33.5x
EV/EBITDA
25.3x
ROIC
12.3%
Bruto marža
58.7%
Neto marža
22.7%
Dividend yield
-
Payout ratio
-
Neto dolg/EBITDA
3.3x
Beta
1.93
Free float
96.6%

O podjetju

TransMedics Group, Inc. (TMDX) is an American company specializing in the development and manufacturing of innovative medical devices for organ transplantation. With the aim of improving the preservation and transportation of organs intended for transplantation, TransMedics has developed the Organ Care System (OCS) technology. This technology allows organs to be maintained in optimal condition during transportation, potentially increasing the success of transplant procedures. The company is known for its commitment to saving lives and innovations in the field of organ transplantation. TransMedics Group, Inc. (TMDX) shares could be suitable for investors looking to invest in a company actively supporting medical research and life-saving through organ transplantation.

Sector

Healthcare

Industry

Medical - Devices

CEO

Waleed H. Hassanein

Employees

898

Headquarters

Andover

Vrednotenje

Je današnja cena primerna?

Rast in ocene

Ali podjetje raste in kaj sledi?

Donosnost in kakovost

Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?

Finančno zdravje

Ali zmore svoj dolg?

Kapital in dividende

Kaj podjetje počne z zasluženim denarjem?

Analitiki

Kaj menijo strokovnjaki in ali se to spreminja?

Lastniki in insajderji

Kdo ima delnice in kaj počne vodstvo?

Segmenti

Kateri del podjetja raste?

Primerjava s konkurenco

Kako se primerja s podobnimi podjetji?

Cena in tveganje

Kako se delnica obnaša?

Izkazi

Vse številke

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.